Study on the Treatment of Differentiated Thyroid Carcinoma with Anlotinib
Study on the Treatment of Differentiated Thyroid Carcinoma with Anlotinib
Active, not recruiting · NCT05007093 · Registry updated 2024-11-07Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study on the Treatment of Differentiated Thyroid Carcinoma with Anlotinib | DTC - Differentiated Thyroid Cancer | Active, not recruiting | Phase 2 | 2024-11-07 | NCT05007093 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Yansong Lin | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Peking Union Medical College Hospital | Beijing | China | 62 |